Transdermal iontophoretic delivery of salmon calcitonin

International Journal of Pharmaceutics

Volumn 200, Issue 1, 2000, Pages 107-113

  Chang, Shu Lun ^a   Hofmann, Günter A ^b   Zhang, Lei ^b   Deftos, Leonard J ^c   Banga, Ajay K ^d  

^a AUBURN UNIVERSITY   (United States)

^b Inovio Biomedical Corporation   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MERCER UNIVERSITY   (United States)

Author keywords

Calcitonin; Iontophoresis; Skin transport; Transdermal

Indexed keywords

SALCATONIN;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; HUMAN TISSUE; IONTOPHORESIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; CALCITONIN; CHEMISTRY, PHARMACEUTICAL; ELECTRODES; EPIDERMIS; HUMANS; HYDROGEN-ION CONCENTRATION; IONTOPHORESIS; ISOELECTRIC FOCUSING; SKIN ABSORPTION;

EID: 0034712895     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00351-3     Document Type: Article

References (14)

1. Arvinte T., Drake A.F. Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants. J. Biol. Chem. 268:1993;6408-6414.
2. Banga A.K. Electrically Assisted Transdermal And Topical Drug Delivery. 1998;Taylor & Francis, London.
3. Bauer H.H., Aebi U., Haner M., Hermann R., Muller M., Arvinte T., Merkle H.P. et al. Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. J. Str. Biol. 115:1995;1-15.
4. Catherwood B.D., Deftos L.J. General principles, problems and interpretation in the radioimmunoassay of calcitonin and parathyroid hormone. Bikle D.D. Assays of Calcium Regulating Hormones. 1984;151-168 Springer-Verlag, New York.
5. Chang, S.L., Hofmann, G.A., Zhang, L., Deftos, L.J., Banga, A.K. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J. Control. Rel. in press.
6. Cullander C., Guy R.H. Routes of delivery: case studies (6) transdermal delivery of peptides and proteins. Adv. Drug Del. Rev. 8:1992;291-329.
7. Deftos L.J. Clinical Essentials Of Calcium And Skeletal Disorders. 1998;1-314 Professional Communications Inc. Caddo, OK.
8. Delgadocharro M.B., Rodriguezbayon A.M., Guy R.H. Iontophoresis of nafarelin: effects of current density and concentration on electrotransport in vitro. J. Control. Release. 35:1995;35-40.
9. Howes D., Guy R., Hadgraft J. et al. Methods for assessing percutaneous absorption-the report and recommendations of ECVAM workshop 13. ATLA Altern. Lab. Anim. 24:1996;81-106.
10. Monteiro-Riviere N.A., Inman A.O., Riviere J.E. Identification of the pathway of iontophoretic drug delivery: light and ultrastructural studies using mercuric chloride in pigs. Pharm. Res. 11(2):1994;251-256.
11. Morimoto K., Iwakura Y., Nakatani E., Miyazaki M., Tojima H. Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats. J. Pharm. Pharmacol. 44:1992;216-218.
12. Rong H., Deftos L.J., Ji H., Bucht E. Two-site immunometric assay of salmon calcitonin with improved sensitivity. Clin. Chem. 43:1997;1-5.
13. Santi P., Colombo P., Bettini R. et al. Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis. Pharm. Res. 14:1997;63-66.
14. Thysman S., Hanchard C., Preat V. Human calcitonin delivery in rats by iontophoresis. J. Pharm. Pharmacol. 46:1994;725-730.